(Q32144479)

6 July 2017

Inhibitory effects of SR141716A on G-protein activation in rat brain (English)

1 reference

6 July 2017

L J Sim-Selley

1

1 reference

6 July 2017

L K Brunk

series ordinal

2

1 reference

6 July 2017

D E Selley

series ordinal

3

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

European Journal of Pharmacology

6 July 2017

1 reference

6 July 2017

414

1 reference

6 July 2017

135-143

1 reference

6 July 2017

2-3

1 reference

Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

A Selective Inverse Agonist for Central Cannabinoid Receptor Inhibits Mitogen-activated Protein Kinase Activation Stimulated by Insulin or Insulin-like Growth Factor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Effects of anandamide on cannabinoid receptors in rat brain membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Cannabinoid modulation of intestinal propulsion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Muscarinic acetylcholine receptor-stimulated binding of guanosine 5'-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Effects of CB(1) cannabinoid receptor activation on cerebellar granule cell nitric oxide synthase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Excitatory transmission to the circular muscle of the guinea-pig ileum: evidence for the involvement of cannabinoid CB1 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

SR 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2+ currents by reversal of tonic CB1 cannabinoid receptor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Structural features of the central cannabinoid CB1 receptor involved in the binding of the specific CB1 antagonist SR 141716A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Differential requirements of sodium for coupling of cannabinoid receptors to adenylyl cyclase in rat brain membranes.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2801%2900784-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-2999(01)00784-1

1 reference

6 July 2017

1 reference